CN Patent

CN108463214A — 液体丁丙诺啡制剂

Assigned to Benovia Treatment Co ltd · Expires 2018-08-28 · 8y expired

What this patent protects

本发明提供了含有丁丙诺啡、其药学上可接受的盐或其衍生物的液体制剂。本发明还提供了含有丁丙诺啡和纳洛酮、其药学上可接受的盐或其衍生物的液体制剂。本发明进一步提供了通过向有需要的患者施用含有丁丙诺啡或丁丙诺啡和纳洛酮的组合物、其药学上可接受的盐或其衍生物的液体制剂来治疗疼痛或阿片类药物依赖性的方法。

USPTO Abstract

本发明提供了含有丁丙诺啡、其药学上可接受的盐或其衍生物的液体制剂。本发明还提供了含有丁丙诺啡和纳洛酮、其药学上可接受的盐或其衍生物的液体制剂。本发明进一步提供了通过向有需要的患者施用含有丁丙诺啡或丁丙诺啡和纳洛酮的组合物、其药学上可接受的盐或其衍生物的液体制剂来治疗疼痛或阿片类药物依赖性的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108463214A
Jurisdiction
CN
Classification
—
Expires
2018-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Benovia Treatment Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.